Genprex to Participate at BIO International Convention 2026
Genprex announced that its executive team will attend the BIO 2026 International Convention in San Diego from June 22-25. Thomas Gallagher, Senior Vice President of Intellectual Property and Licensing, will be available for one-on-one meetings to discuss the company's gene therapies for cancer and diabetes.
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.